The global Rosuvastatin Calcium Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Rosuvastatinis an HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke.
This report aims to provide a comprehensive presentation of the global market for Rosuvastatin Calcium Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rosuvastatin Calcium Drug. This report contains market size and forecasts of Rosuvastatin Calcium Drug in global, including the following market information:
- Global Rosuvastatin Calcium Drug Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global Rosuvastatin Calcium Drug Market Sales, 2018-2023, 2024-2032, (K Units)
- Global top five Rosuvastatin Calcium Drug companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Capsules Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Rosuvastatin Calcium Drug include Accord Healthcare, Angita Pharma, Actavis Pharma, A-S Medication Solutions, AstraZeneca Pharmaceuticals, PD-Rx Pharmaceuticals, Sandoz, Lunan Pharmaceutical Group and Chia-Tai Tianqing Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Rosuvastatin Calcium Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rosuvastatin Calcium Drug Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Rosuvastatin Calcium Drug Market Segment Percentages, by Type, 2022 (%)
Global Rosuvastatin Calcium Drug Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Rosuvastatin Calcium Drug Market Segment Percentages, by Application, 2022 (%)
Global Rosuvastatin Calcium Drug Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Rosuvastatin Calcium Drug Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Rosuvastatin Calcium Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Rosuvastatin Calcium Drug revenues share in global market, 2022 (%)
- Key companies Rosuvastatin Calcium Drug sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Rosuvastatin Calcium Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Accord Healthcare
- Angita Pharma
- Actavis Pharma
- A-S Medication Solutions
- AstraZeneca Pharmaceuticals
- PD-Rx Pharmaceuticals
- Sandoz
- Lunan Pharmaceutical Group
- Chia-Tai Tianqing Pharmaceutical
- Hisun Pharmaceutical
- Jinan Jinda
- Jingxin Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rosuvastatin Calcium Drug, market overview.
Chapter 2: Global Rosuvastatin Calcium Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Rosuvastatin Calcium Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rosuvastatin Calcium Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Rosuvastatin Calcium Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
